JP Patent
JP4959918B2 — Flt3レセプター・チロシン・キナーゼ活性インヒビターとしてのスタウロスポリン誘導体
Assigned to ノバルティス アーゲー · Expires 2012-06-27 · 14y expired
What this patent protects
Patent listed against Rydapt.
Drugs covered by this patent
- Rydapt (MIDOSTAURIN) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.